MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targeting
Silvia Pomella(University of Rome Tor Vergata), Rossella Rota(Bambino Gesù Children's Hospital)
Cited by 21
Related Papers
MicroRNA-101 is repressed by EZH2 and its restoration inhibits tumorigenic features in embryonal rhabdomyosarcoma
|Clinical Epigenetics|2015|41
Hyper-Activation of Notch3 Amplifies the Proliferative Potential of Rhabdomyosarcoma Cells
|PLoS ONE|2014|15